Skip to main content
Thoth
Open Book Publishers

  1. Bioprospecting and Testing of New Fly Species for Maggot Therapy

Export Metadata

Metadata
Title
  1. Bioprospecting and Testing of New Fly Species for Maggot Therapy
ContributorPatricia J. Thyssen(author)
Franciéle S. Masiero(author)
Frank Stadler(author)
DOIhttps://doi.org/10.11647/obp.0300.11
Landing pagehttps://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.11
Licensehttps://creativecommons.org/licenses/by-nc/4.0/
CopyrightPatricia J. Thyssen; Franciéle S. Masiero; Frank Stadler
PublisherOpen Book Publishers
Publication placeCambridge, UK
Published on2022-07-20
Long abstract
Page rangepp. 195–234
LanguageEnglish (Original)

Contributors

Patricia J. Thyssen

(author)
Assistant Professor of Entomology and Parasitology at Universidade Estadual de Campinas

Franciéle S. Masiero

(author)

Frank Stadler

(author)
Adjunct Fellow at Applied BioSciences at Macquarie University
Adjunct Research Fellow at Griffith University

References

  1. 1. Harvey, M., The Natural History of Medicinal Flies, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 121–142, https://doi.org/10.11647/OBP.0300.07.(opens in new tab)
  2. 2. Stadler, F., et al., Fly Colony Establishment, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 257–288 (p. 269), https://doi.org/10.11647/OBP.0300.13.(opens in new tab)
  3. 3. Courtney, G.W., et al., Biodiversity of Diptera, in Insect Biodiversity: Science and Society, R.G. Foottit and P.H. Adler (eds). 2017, Wiley-Blackwell: New Jersey, USA, pp. 229–278.
  4. 4. Stadler, F., Laboratory and Insectary Infrastructure and Equipment, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 237–256, https://doi.org/10.11647/OBP.0300.12.(opens in new tab)
  5. 5. Stadler, F., Packaging Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 349–362, https://doi.org/10.11647/OBP.0300.16. (opens in new tab)
  6. 6. Stadler, F., Distribution Logistics, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 363–382, https://doi.org/10.11647/OBP.0300.17.(opens in new tab)
  7. 7. Stadler, F. and P. Takáč, Medicinal Maggot Production, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 289–330, https://doi.org/10.11647/OBP.0300.14.(opens in new tab)
  8. 8. Stadler, F. and P. Tatham, Drone-assisted Medicinal Maggot Distribution in Compromised Healthcare Settings, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 383–402, https://doi.org/10.11647/OBP.0300.18.(opens in new tab)
  9. 9. Takáč, P., et al., and F. Stadler, Establishment of a Medicinal Maggot Production Facility and Treatment Programme in Kenya, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 289–330, https://doi.org/10.11647/OBP.0300.14.(opens in new tab)
  10. 10. Bernhardt, V., et al., Myiasis in Humans-A Global Case Report Evaluation and Literature Analysis. Parasitology Research, 2019. 118(2): pp. 389–397, https://doi.org/10.1007/s00436-018-6145-7. (opens in new tab)
  11. 11. Loureiro, J.F., et al., [Colon Myiasis]. Revista da Associacao Medica Brasileira, 2010. 56(6): p. 638, https://doi.org/10.1590/s0104-42302010000600008. (opens in new tab)
  12. 12. Marcondes, C.B., Dermatobia Hominis (Diptera: Cuterebridae) in Africa and the Need for Caution in its Taxonomy. Journal of Infection and Public Health, 2014. 7(1): pp. 73–74, https://doi.org/10.1016/j.jiph.2013.07.007. (opens in new tab)
  13. 13. Osorio, J.H., Diagnostic Mistake and Wrong Treatment of Cutaneous Myiasis by Cochliomyia Hominivorax (Coquerel) (Diptera: Calliphoridae). Brazilian Journal of Biological Sciences, 2016. 3(5): pp. 231–239.
  14. 14. Carvalho, L.M.L., et al. Observations on the Succession Patterns of Necrophagous Insects on a Pig Carcass in an Urban Area of Southeastern Brazil. Anil Aggrawals Internet Journal of Forensic Medicine and Toxicology 2004 5(1) ; pp. 33–39.
  15. 15. Azeredo-Espin, A.M. and N.G. Madeira, Primary Myiasis in Dog Caused by Phaenicia Eximia (Diptera:Calliphoridae) and Preliminary Mitochondrial DNA Analysis of the Species in Brazil. J Med Entomol, 1996. 33(5): pp. 839–843, https://doi.org/10.1093/jmedent/33.5.839. (opens in new tab)
  16. 16. Cansi, E.R., et al., Myiasis by Screw Worm Cochliomyia Hominivorax (Coquerel) (Diptera: Calliphoridae) in a Wild Maned Wolf Chrysocyon Brachyurus (Mammalia: Canidae), in Brasília, Brazil. Neotropical Entomology, 2011. 40(1): pp. 150–151, https://doi.org/10.1590/s1519-566x2011000100025. (opens in new tab)
  17. 17. Moretti, T.C. and P.J. Thyssen, Miíase primária em coelho doméstico causada por Lucilia eximia (Diptera: Calliphoridae) no Brasil: relato de caso. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, 2006. 58(1): pp. 28–30, https://doi.org/10.1590/S0102-09352006000100005. (opens in new tab)
  18. 18. Hall, M. and R. Wall, Myiasis of Humans and Domestic Animals. Advances in Parasitololgy, 1995. 35: pp. 257–334, https://doi.org/10.1016/s0065-308x(08)60073-1. (opens in new tab)
  19. 19. Stevens, J. and R. Wall, Species, Sub-species and Hybrid Populations of the Blowflies Lucilia cuprina and Lucilia sericata (Diptera:Calliphoridae). Proceedings Biological Sciences, 1996. 263(1375): pp. 1335–1341, https://doi.org/10.1098/rspb.1996.0196. (opens in new tab)
  20. 20. Stevens, J. and R. Wall, The Evolution of Ectoparasitism in the Genus Lucilia (Diptera:Calliphoridae). International Journal for Parasitology, 1997. 27(1): pp. 51–59, https://doi.org/10.1016/s0020-7519(96)00155-5. (opens in new tab)
  21. 21. Stevens, J. and R. Wall, Genetic Variation in Populations of the Blowflies Lucilia cuprina and Lucilia sericata (Diptera: Calliphoridae). Random Amplified Polymorphic DNA Analysis and Mitochondrial DNA Sequences. Biochemical Systematics and Ecology, 1997. 25(2): pp. 81–97, https://doi.org/10.1016/S0305-1978(96)00038-5. (opens in new tab)
  22. 22. Tantawi, T.I., K.A. Williams, and M.H. Villet, An Accidental but Safe and Effective Use of Lucilia cuprina (Diptera: Calliphoridae) in Maggot Debridement Therapy in Alexandria, Egypt. Journal of Medical Entomology, 2010. 47(3): pp. 491–494, https://doi.org/10.1093/jmedent/47.3.491. (opens in new tab)
  23. 23. Thyssen, P.J., et al., Implications of Entomological Evidence during the Investigation of Five Cases of Violent Death in Southern Brazil. Journal of Forensic Science and Research, 2018. 2: pp. 001–008, https://doi.org/10.29328/journal.jfsr.1001013. (opens in new tab)
  24. 24. Faria, L.D.B., L.A. Trinca, and W.A.C. Godoy, Cannibalistic Behavior and Functional Response in Chysomya Albiceps (Diptera: Calliphoridae). Journal of Insect Behavior, 2004. 17: pp. 251–261, https://dx.doi.org/10.1023/B:JOIR.0000028574.91062.18. (opens in new tab)
  25. 25. Spindola, A.F., et al., Attraction and Oviposition of Lucilia eximia (Diptera: Calliphoridae) to Resources Colonized by the Invasive Competitor Chrysomya albiceps (Diptera: Calliphoridae). Journal of Medical Entomology, 2017. 54(2): pp. 321–328, https://doi.org/10.1093/jme/tjw170. (opens in new tab)
  26. 26. Rosa, G.S., et al., The Dynamics of Intraguild Predation in Chrysomya albiceps Wied. (Diptera: Calliphoridae): Interactions between Instars and Species under Different Abundances of Food. Neotropical Entomology, 2006. 35(6): p. 775–780, https://doi.org/10.1590/s1519-566x2006000600009. (opens in new tab)
  27. 27. Blake, F.A., et al., The Biosurgical Wound Debridement: Experimental Investigation of Efficiency and Practicability. Wound Repair and Regeneration, 2007. 15(5): pp. 756–761, https://doi.org/10.1111/j.1524-475X.2007.00298.x. (opens in new tab)
  28. 28. Dini, V., et al., Correlation Between Wound Temperature Obtained With an Infrared Camera and Clinical Wound Bed Score in Venous Leg Ulcers. Wounds, 2015. 27(10): pp. 274–278 http://www.woundsresearch.com/article/correlation-between-wound-temperature-obtained-infrared-camera-and-clinical-wound-bed-score.
  29. 29. McGuiness, W., E. Vella, and D. Harrison, Influence of Dressing Changes on Wound Temperature. Journal of Wound Care, 2004. 13(9): pp. 383–385, https://doi.org/10.12968/jowc.2004.13.9.26702. (opens in new tab)
  30. 30. Chernysh, S., et al., Antiviral and Antitumor Peptides from Insects. Procedings of the National Academie of Science of the Unites States of America, 2002. 99(20): pp. 12628–12632, https://doi.org/10.1073/pnas.192301899. (opens in new tab)
  31. 31. El Shazely, B., et al., Lucifensin II, a Defensin of Medicinal Maggots of the Blowfly Lucilia cuprina (Diptera: Calliphoridae). Journal of Medical Entomology, 2013. 50(3): pp. 571–578, https://doi.org/10.1603/me12208. (opens in new tab)
  32. 32. Téllez, G.A., et al., Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide. Acta Tropica, 2018. 185: pp. 318–326, https://doi.org/10.1016/j.actatropica.2018.06.003. (opens in new tab)
  33. 33. Ceřovský, V., et al., Lucifensin, a Novel Insect Defensin of Medicinal Maggots: Synthesis and Structural Study. ChemBioChem, 2011. 12(9): pp. 1352–1361, https://doi.org/10.1002/cbic.201100066. (opens in new tab)
  34. 34. Pöppel, A.K., et al., Lucimycin, an Antifungal Peptide from the Therapeutic Maggot of the Common Green Bottle Fly Lucilia sericata. Biological Chemistry, 2014. 395(6): pp. 649–656, https://doi.org/10.1515/hsz-2013-0263. (opens in new tab)
  35. 35. Lambert, J., et al., Insect Immunity: Isolation from Immune Blood of the Dipteran Phormia Terranovae of Two Insect Antibacterial Peptides with Sequence Homology to Rabbit Lung Macrophage Bactericidal Peptides. Proceedings of the National Academie of the United States of America, 1989. 86(1): pp. 262–266, https://doi.org/10.1073/pnas.86.1.262. (opens in new tab)
  36. 36. Díaz-Roa, A., et al., Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions. Molecules, 2019. 24(11), https://doi.org/10.3390/molecules24112077. (opens in new tab)
  37. 37. Díaz-Roa, A., et al., Sarconesin: Sarconesiopsis magellanica Blowfly Larval Excretions and Secretions with Antibacterial Properties. Frontiers in Microbiology, 2018. 9(2249): pp. 1–13, https://doi.org/10.3389/fmicb.2018.02249. (opens in new tab)
  38. 38. Dallavecchia, D.L., et al., Antibacterial and Antifungal Activity of Excretions and Secretions of Calliphora Vicina. Medical and Veterinary Entomology, 2021. 35(2): pp. 225–229, https://doi.org/10.1111/mve.12486. (opens in new tab)
  39. 39. Sanei-Dehkordi, A., et al., Anti Leishmania Activity of Lucilia sericata and Calliphora vicina Maggots in Laboratory Models. Experimental Parasitology, 2016. 170: p. 59–65, https://doi.org/10.1016/j.exppara.2016.08.007. (opens in new tab)
  40. 40. Ratcliffe, N.A., et al., Detection and Preliminary Physico-chemical Properties of Antimicrobial Components in the Native Excretions/Secretions of Three Species of Chrysomya (Diptera, Calliphoridae) in Brazil. Acta Tropica, 2015. 147: pp. 6–11, https://doi.org/10.1016/j.actatropica.2015.03.021. (opens in new tab)
  41. 41. Mohamed, N.T., Fractionation and Purification of Bioactive Peptides in Excretory/Secretory Products of Third Instar Larvae of Chrysomya Megacephala (Calliphoridae: Diptera). Bulletin of Envrionment, Pharmacy and Life Sciences, 2015. 4(10): pp. 69–74.
  42. 42. Fonseca-Muñoz, A., et al., Bactericidal Activity of Chrysomya rufifacies and Cochliomyia macellaria (Diptera: Calliphoridae) Larval Excretions-Secretions Against Staphylococcus aureus (Bacillales: Staphylococcaceae). Journal of Medical Entomology, 2019. 56(6): pp. 1598–1604, https://doi.org/10.1093/jme/tjz109. (opens in new tab)
  43. 43. Masiero, F.S., et al., First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa. Neotropical Entomology, 2017. 46(1): pp. 125–129, https://doi.org/10.1007/s13744-016-0444-4. (opens in new tab)
  44. 44. Abdel-Samad, M.R.K., Antiviral and Virucidal Activities of Lucilia cuprina Maggots’ Excretion/Secretion (Diptera: Calliphoridae): First Work. Heliyon, 2019. 5(11): e02791, https://doi.org/10.1016/j.heliyon.2019.e02791. (opens in new tab)
  45. 45. Arora, S., C. Baptista, and C.S. Lim, Maggot Metabolites and Their Combinatory Effects with Antibiotic on Staphylococcus aureus. Annals of Clinical Microbiology and Antimicrobials, 2011. 10(6): pp. 1–8, https://doi.org/10.1186/1476-0711-10-6. (opens in new tab)
  46. 46. Teh, C.H., et al., In vitro Antibacterial Activity and Physicochemical Properties of a Crude Methanol Extract of the Larvae of the Blow Fly Lucilia cuprina. Medical and Veterinary Entomology, 2013. 27(4): pp. 414–420, https://doi.org/10.1111/mve.12012. (opens in new tab)
  47. 47. Polat, E., et al., Treatment of Pressure Ulcers with Larvae of Lucilia sericata. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 2017. 63(4): pp. 307–312, https://doi.org/10.5606/tftrd.2017.851. (opens in new tab)
  48. 48. Thomas, S., et al., The Anti-microbial Activity of Maggot Secretions: Results of a Preliminary Study. Journal of Tissue Viability, 1999. 9(4): pp. 127–132, https://doi.org/10.1016/s0965-206x(99)80032-1. (opens in new tab)
  49. 49. Laverde-Paz, M.J., et al., Evaluating the Anti-leishmania Activity of Lucilia sericata and Sarconesiopsis magellanica Blowfly Larval Excretions/Secretions in an in vitro Model. Acta Tropica, 2018. 177: pp. 44–50, https://doi.org/10.1016/j.actatropica.2017.09.033. (opens in new tab)
  50. 50. Fu, P., J. Wu, and G. Guo, Purification and Molecular Identification of an Antifungal Peptide from the Hemolymph of Musca domestica (Housefly). Cellular & Molecular Immunology, 2009. 6(4): pp. 245–251, https://doi.org/10.1038/cmi.2009.33. (opens in new tab)
  51. 51. Díaz-Roa, A., et al., Sarconesiopsis magellanica (Diptera: Calliphoridae) Excretions and Secretions Have Potent Antibacterial Activity. Acta Tropica, 2014. 136: pp. 37–43, https://doi.org/10.1016/j.actatropica.2014.04.018. (opens in new tab)
  52. 52. Góngora, J., et al., Evaluación de la actividad antibacterial de los extractos de cuerpos grasos y hemolinfa derivados de la mosca Sarconesiopsis magellanica (Diptera: Calliphoridae). Infectio, 2015. 19(1): pp. 3–9, https://doi.org/10.1016/j.infect.2014.09.003. (opens in new tab)
  53. 53. Gordya, N., et al., Natural Antimicrobial Peptide Complexes in the Fighting of Antibiotic Resistant Biofilms: Calliphora vicina Medicinal Maggots. PLoS ONE, 2017. 12(3): e0173559, https://doi.org/10.1371/journal.pone.0173559. (opens in new tab)
  54. 54. Harris, L.G., et al., Disruption of Staphylococcus epidermidis Biofilms by Medicinal Maggot Lucilia sericata Excretions/Secretions. International Journal of Artificial Organs, 2009. 32(9): pp. 555–564, https://doi.org/10.1177/039139880903200904. (opens in new tab)
  55. 55. Jiang, K.C., et al., Excretions/Secretions from Bacteria-pretreated Maggot Are More Effective against Pseudomonas aeruginosa Biofilms. PLoS ONE, 2012. 7(11): e49815, https://doi.org/10.1371/journal.pone.0049815. (opens in new tab)
  56. 56. van der Plas, M.J., et al., Combinations of Maggot Excretions/Secretions and Antibiotics Are Effective against Staphylococcus aureus Biofilms and the Bacteria Derived Therefrom. Journal of Antimicrobial Chemotherapy, 2010. 65(5): pp. 917–923, https://doi.org/10.1093/jac/dkq042. (opens in new tab)
  57. 57. van der Plas, M.J., et al., Maggot Excretions/Secretions Are Differentially Effective against Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 2008. 61(1): pp. 117–122, https://doi.org/10.1093/jac/dkm407. (opens in new tab)
  58. 58. Cazander, G., et al., Synergism between Maggot Excretions and Antibiotics. Wound Repair and Regeneration, 2010. 18(6): pp. 637–642, https://doi.org/10.1111/j.1524-475X.2010.00625.x. (opens in new tab)
  59. 59. Masiero, F.S., et al., In vitro Evaluation of the Association of Medicinal Larvae (Insecta, Diptera, Calliphoridae) and Topical Agents Conventionally Used for the Treatment of Wounds. Acta Tropica, 2019. 190: pp. 68–72, https://doi.org/10.1016/j.actatropica.2018.10.015. (opens in new tab)
  60. 60. Horobin, A.J., K.M. Shakesheff, and D.I. Pritchard, Promotion of Human Dermal Fibroblast Migration, Matrix Remodelling and Modification of Fibroblast Morphology within a Novel 3D Model by Lucilia sericata Larval Secretions. The Journal of Investigative Dermatology, 2006. 126(6): pp. 1410–1408, https://doi.org/10.1038/sj.jid.5700256. (opens in new tab)
  61. 61. van der Plas, M.J., et al., Maggot Secretions Suppress Pro-inflammatory Responses of Human Monocytes through Elevation of Cyclic AMP. Diabetologia, 2009. 52(9): pp. 1962–1970, https://doi.org/10.1007/s00125-009-1432-6. (opens in new tab)
  62. 62. Bexfield, A., et al., Amino Acid Derivatives from Lucilia sericata Excretions/Secretions May Contribute to the Beneficial Effects of Maggot Therapy via Increased Angiogenesis. British Journal of Dermatology, 2010. 162(3): pp. 554–562, https://doi.org/10.1111/j.1365-2133.2009.09530.x. (opens in new tab)
  63. 63. Wang, S.Y., et al., Maggot Excretions/Secretions Induces Human Microvascular Endothelial Cell Migration through AKT1. Molecular Biology Reports, 2010. 37(6): pp. 2719–2725, https://doi.org/10.1007/s11033-009-9806-x. (opens in new tab)
  64. 64. Linger, R.J., et al., Towards Next Generation Maggot Debridement Therapy: Transgenic Lucilia sericata Larvae that Produce and Secrete a Human Growth Factor. BMC Biotechnology, 2016. 16(30): pp. 1–12, https://doi.org/10.1186/s12896-016-0263-z. (opens in new tab)
  65. 65. Čičková, H., M. Kozánek, and P. Takáč, Growth and Survival of Blowfly Lucilia sericata Larvae under Simulated Wound Conditions: Implications for Maggot Debridement Therapy. Medical and Veterinary Entomology, 2015. 29(4): pp. 416–424, https://doi.org/10.1111/mve.12135. (opens in new tab)
  66. 66. Wilson, M.R., et al., The Impacts of Larval Density and Protease Inhibition on Feeding in Medicinal Larvae of the Greenbottle Fly Lucilia sericata. Med Vet Entomol, 2016. 30(1): pp. 1–7, https://doi.org/10.1111/mve.12138. (opens in new tab)
  67. 67. Rajamohan, A., J.P. Rinehart, and R.A. Leopold, Cryopreservation of Embryos of Lucilia sericata (Diptera: Calliphoridae). Journal of Medical Entomology, 2014. 51(2): pp. 360–367, https://doi.org/10.1603/me13188. (opens in new tab)
  68. 68. Brundage, A.L., T.L. Crippen, and J.K. Tomberlin, Methods for External Disinfection of Blow Fly (Diptera: Calliphoridae) Eggs prior to Use in Wound Debridement Therapy. Wound Repair Regen, 2016. 24(2): pp. 384–393, https://doi.org/10.1111/wrr.12408. (opens in new tab)
  69. 69. Thyssen, P.J., et al., Sterilization of Immature Blowflies (Calliphoridae) for Use in Larval Therapy. Journal of Medicine and Medical Sciences, 2013. 4(10): pp. 405–409 https://www.interesjournals.org/articles/sterilization-of-immature-blowflies-calliphoridae-for-use-in-larval-therapy.pdf.
  70. 70. Dallavecchia, D.L., et al., Efficacy of UV-C Ray Sterilization of Calliphora vicina (Diptera: Calliphoridae) Eggs for Use in Maggot Debridement Therapy. Journal of Medical Entomology, 2019. 56(1): pp. 40–44, https://doi.org/10.1093/jme/tjy140. (opens in new tab)
  71. 71. Limsopatham, K., et al., Sterilization of Blow Fly Eggs, Chrysomya megacephala and Lucilia cuprina, (Diptera: Calliphoridae) for Maggot Debridement Therapy Application. Parasitology Research, 2017. 116(5): pp. 1581–1589, https://doi.org/10.1007/s00436-017-5435-9. (opens in new tab)
  72. 72. Mohd Masri, S., et al., Sterilisation of Lucilia cuprina Wiedemann Maggots Used in Therapy of Intractable Wounds. Tropical Biomedicine, 2005. 22(2): pp. 185–189.
  73. 73. Nassu, M.P. and P.J. Thyssen, Evaluation of Larval Density Cochliomyia macellaria F. (Diptera: Calliphoridae) for Therapeutic Use in the Recovery of Tegumentar Injuries. Parasitology Research, 2015. 114(9): pp. 3255–3260, https://doi.org/10.1007/s00436-015-4542-8. (opens in new tab)
  74. 74. Parrado, A.E.R., et al., Terapia Larval con Musca domestica en el tratamiento de la úlcera leishmánica en un modelo murino. Acta Biológica Colombiana, 2020. 25(1): pp. 82–95, https://doi.org/10.15446/abc.v25n1.77177. (opens in new tab)
  75. 75. Cruz-Saavedra, L., et al., The Effect of Lucilia sericata- and Sarconesiopsis magellanica-derived Larval Therapy on Leishmania panamensis. Acta Tropica, 2016. 164: pp. 280–289, https://doi.org/10.1016/j.actatropica.2016.09.020. (opens in new tab)
  76. 76. Zhang, Z., et al., Activity of Antibacterial Protein from Maggots against Staphylococcus aureus in vitro and in vivo. International Journal of Molecular Medicine, 2013. 31(5): pp. 1159–1165, https://doi.org/10.3892/ijmm.2013.1291. (opens in new tab)
  77. 77. Arrivillaga, J., J. Rodríguez, and M. Oviedo, [Preliminary Evaluation of Maggot (Diptera: Calliphoridae) Therapy as a Potential Treatment for Leishmaniasis Ulcers]. Biomédica, 2008. 28(2): pp. 305–310, https://dx.doi.org/10.7705/biomedica.v28i2.102. (opens in new tab)
  78. 78. Masiero, F.S., et al., Histological Patterns in Healing Chronic Wounds Using Cochliomyia macellaria (Diptera: Calliphoridae) Larvae and Other Therapeutic Measures. Parasitology Research, 2015. 114(8): pp. 2865–2872, https://doi.org/10.1007/s00436-015-4487-y. (opens in new tab)
  79. 79. Masiero, F.S. and P.J. Thyssen, Evaluation of Conventional Therapeutic Methods versus Maggot Therapy in the Evolution of Healing of Tegumental Injuries in Wistar Rats with and without Diabetes mellitus. Parasitology Research, 2016. 115(6): pp. 2403–2407, https://doi.org/10.1007/s00436-016-4991-8. (opens in new tab)
  80. 80. Hassan, M.I., et al., The Using of Lucilia cuprina Maggots in the Treatment of Diabetic Foot Wounds. Journal of the Egyptian Society of Parasitology, 2014. 44(1): pp. 125–129, https://doi.org/10.12816/0006451. (opens in new tab)
  81. 81. Li, P.N., et al., Molecular Events Underlying Maggot Extract Promoted Rat in vivo and Human in vitro Skin Wound Healing. Wound Repair and Regeneration, 2015. 23(1): pp. 65–73, https://doi.org/10.1111/wrr.12243. (opens in new tab)
  82. 82. Díaz-Roa, A., et al., Evaluating Sarconesiopsis magellanica Blowfly-derived Larval Therapy and Comparing It to Lucilia sericata-derived Therapy in an Animal Model. Acta Tropica, 2016. 154: pp. 34–41, https://doi.org/10.1016/j.actatropica.2015.10.024. (opens in new tab)
  83. 83. Tombulturk, F.K., et al., Effects of Lucilia sericata on Wound Healing in Streptozotocin-induced Diabetic Rats and Analysis of Its Secretome at the Proteome Level. Human & Experimental Toxicology, 2018. 37(5): pp. 508–520, https://doi.org/10.1177/0960327117714041. (opens in new tab)
  84. 84. Zhang, Z., et al., Fatty Acid Extracts from Lucilia sericata Larvae Promote Murine Cutaneous Wound Healing by Angiogenic Activity. Lipids in Health and Disease, 2010. 9(24): pp. 1–9, https://doi.org/10.1186/1476-511x-9-24. (opens in new tab)
  85. 85. Góngora, J., et al., Evaluating the Effect of Sarconesiopsis magellanica (Diptera: Calliphoridae) Larvae-derived Haemolymph and Fat Body Extracts on Chronic Wounds in Diabetic Rabbits. Journal of Diabetes Research, 2015. 2015: p. 270253, https://doi.org/10.1155/2015/270253. (opens in new tab)
  86. 86. Arora, S., L.C. Sing, and C. Baptista, Antibacterial Activity of Lucilia cuprina Maggot Extracts and Its Extraction Techniques. International Journal of Integrative Biology, 2010. 9(1): pp. 43–48.
  87. 87. Bernhardt, V., et al., Of Pigs and Men-Comparing the Development of Calliphora vicina (Diptera: Calliphoridae) on Human and Porcine Tissue. International Journal of Legal Medicine, 2017. 131(3): pp. 847–853, https://doi.org/10.1007/s00414-016-1487-0. (opens in new tab)
  88. 88. Clark, K., L. Evans, and R. Wall, Growth Rates of the Blowfly, Lucilia sericata, on Different Body Tissues. Forensic Science International, 2006. 156(2–3): pp. 145–149, https://doi.org/10.1016/j.forsciint.2004.12.025. (opens in new tab)
  89. 89. Figueroa, L., et al., Experiencia de terapia larval en pacientes con úlceras crónicas. Parasitología Latinoamericana, 2006. 61: pp. 160–164.
  90. 90. Pinheiro, M.A., et al., Use of Maggot Therapy for Treating a Diabetic Foot Ulcer Colonized by Multidrug Resistant Bacteria in Brazil. Indian Journal of Medical Research, 2015. 141(3): pp. 340–342 https://journals.lww.com/ijmr/Fulltext/2015/41030/Use_of_maggot_therapy_for_treating_a_diabetic_foot.13.aspx.
  91. 91. Wolff, M.I., et al., Lucilia eximia (Diptera: Calliphoridae), una nueva alternativa para la terapia larval y reporte de casos en Colombia. Iatreia, 2010. 23(2): pp. 107–116.
  92. 92. Steenvoorde, P., C.E. Jacobi, and J. Oskam, Maggot Debridement Therapy: Free-range or Contained? An in-vivo Study. Advances in Skin & Wound Care, 2005. 18(8): pp. 430–435, https://doi.org/10.1097/00129334-200510000-00010. (opens in new tab)
  93. 93. Thomas, S., et al., The Effect of Containment on the Properties of Sterile Maggots. British Journal of Nursing, 2002. 11(12 Suppl): pp. S21–22, S24, S26 passim, https://doi.org/10.12968/bjon.2002.11.Sup2.10294. (opens in new tab)
  94. 94. Estrada, D.A., et al., [Chrysomya albiceps (Wiedemann) (Diptera: Calliphoridae) Developmental Rate on Artificial Diet with Animal Tissues for Forensic Purpose]. Neotropical Entomology, 2009. 38(2): pp. 203–207, https://doi.org/10.1590/s1519-566x2009000200006. (opens in new tab)
  95. 95. Masiero, F.S., et al., First Report on the Use of Larvae of Cochliomyia macellaria (Diptera: Calliphoridae) for Wound Treatment in Veterinary Practice. Journal of Medical Entomology, 2020. 57(3): pp. 965–968, https://doi.org/10.1093/jme/tjz238. (opens in new tab)
  96. 96. Guyatt, G.H., et al., GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations. BMJ, 2008. 336(7650): pp. 924–926, https://doi.org/10.1136/bmj.39489.470347.AD. (opens in new tab)
  97. 97. Hanson, B.P., Designing, Conducting and Reporting Clinical Research. A Step by Step Approach. Injury, 2006. 37(7): pp. 583–594, https://doi.org/10.1016/j.injury.2005.06.051. (opens in new tab)
  98. 98. IDF. IDF Diabetes Atlas. 2021. https://diabetesatlas.org/.
  99. 99. Sherman, R.A. and M.R. Hetzler, Maggot Therapy for Wound Care in Austere Environments. Journal of Special Operations Medicine, 2017. 17(2): pp. 154–162.
  100. 100. Stadler, F., R.Z. Shaban, and P. Tatham, Maggot Debridement Therapy in Disaster Medicine. Prehospital and Disaster Medicine, 2016. 31(1): pp. 79–84, https://doi.org/10.1017/s1049023x15005427. (opens in new tab)
  101. 101. Sherman, R.A., Maggot Therapy for Treating Diabetic Foot Ulcers Unresponsive to Conventional Therapy. Diabetes Care, 2003. 26(2): pp. 446–451, https://doi.org/10.2337/diacare.26.2.446. (opens in new tab)
  102. 102. Armstrong, D.G., et al., Maggot Therapy in “Lower-extremity Hospice” Wound Care: Fewer Amputations and More Antibiotic-free Days. Journal of the American Podiatric Medical Association, 2005. 95(3): pp. 254–257, https://doi.org/10.7547/0950254. (opens in new tab)
  103. 103. Wang, S.Y., et al., Clinical Research on the Bio-debridement Effect of Maggot Therapy for Treatment of Chronically Infected Lesions. Orthopaedic Surgery, 2010. 2(3): pp. 201–206, https://doi.org/10.1111/j.1757-7861.2010.00087.x. (opens in new tab)
  104. 104. Gilead, L., K.Y. Mumcuoglu, and A. Ingber, The Use of Maggot Debridement Therapy in the Treatment of Chronic Wounds in Hospitalised and Ambulatory Patients. Journal of Wound Care, 2012. 21(2): pp. 78, 80, 82–85, https://doi.org/10.12968/jowc.2012.21.2.78. (opens in new tab)
  105. 105. Bowling, F.L., E.V. Salgami, and A.J. Boulton, Larval Therapy: A Novel Treatment in Eliminating Methicillin-resistant Staphylococcus aureus from Diabetic Foot Ulcers. Diabetes Care, 2007. 30(2): pp. 370–371, https://doi.org/10.2337/dc06-2348. (opens in new tab)
  106. 106. Paul, A.G., et al., Maggot Debridement Therapy with Lucilia cuprina: A Comparison with Conventional Debridement in Diabetic Foot Ulcers. International Wound Journal, 2009. 6(1): pp. 39–46, https://doi.org/10.1111/j.1742-481X.2008.00564.x. (opens in new tab)
  107. 107. Szczepanowski, Z., et al., Microbiological Effects in Patients with Leg Ulcers and Diabetic Foot Treated with Lucilia sericata Larvae. International Wound Journal, 2022. 19(1): pp. 135–143, https://doi.org/10.1111/iwj.13605. (opens in new tab)
  108. 108. Wilasrusmee, C., et al., Maggot Therapy for Chronic Ulcer: A Retrospective Cohort and a Meta-analysis. Asian Journal of Surgery, 2014. 37(3): pp. 138–147, https://doi.org/10.1016/j.asjsur.2013.09.005. (opens in new tab)
  109. 109. Sun, X., et al., A Systematic Review of Maggot Debridement Therapy for Chronically Infected Wounds and Ulcers. International Journal of Infectious Diseases, 2014. 25: pp. 32–37, https://doi.org/10.1016/j.ijid.2014.03.1397. (opens in new tab)
  110. 110. Davies, C.E., et al., Maggots as a Wound Debridement Agent for Chronic Venous Leg Ulcers under Graduated Compression Bandages: A Randomised Controlled Trial. Phlebology, 2015. 30(10): pp. 693–699, https://doi.org/10.1177/0268355514555386. (opens in new tab)
  111. 111. Malekian, A., et al., Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial. Journal of Wound, Ostomy and Continence Nursing, 2019. 46(1): pp. 25–29, https://doi.org/10.1097/won.0000000000000496. (opens in new tab)
  112. 112. Dumville, J.C., et al., Larval Therapy for Leg Ulcers (VenUS II): Randomised Controlled Trial. BMJ, 2009. 338: p. b773, https://doi.org/10.1136/bmj.b773. (opens in new tab)
  113. 113. Soares, M.O., et al., Cost Effectiveness Analysis of Larval Therapy for Leg Ulcers. BMJ, 2009. 338: p. b825, https://doi.org/10.1136/bmj.b825. (opens in new tab)
  114. 114. Contreras-Ruiz, J., et al., [Comparative Study of the Efficacy of Larva Therapy for Debridement and Control of Bacterial Burden Compared to Surgical Debridement and Topical Application of an Antimicrobial]. Gaceta médica de México, 2016. 152(Suppl 2): pp. 78–87, http://www.anmm.org.mx/GMM/2016/s2/GMM_152_2016_S2_78-87.pdf.
  115. 115. Opletalová, K., et al., Maggot Therapy for Wound Debridement: A Randomized Multicenter Trial. Archives of Dermatology, 2012. 148(4): pp. 432–438, https://doi.org/10.1001/archdermatol.2011.1895. (opens in new tab)
  116. 116. Mudge, E., et al., A Randomized Controlled Trial of Larval Therapy for the Debridement of Leg Uulcers: Results of a Multicenter, Randomized, Controlled, Open, Observer Blind, Parallel Group Study. Wound Repair Regen, 2014. 22(1): pp. 43–51, https://doi.org/10.1111/wrr.12127. (opens in new tab)
  117. 117. Stadler, F., The Ethics of Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 405–430, https://doi.org/10.11647/OBP.0300.19.(opens in new tab)
  118. 118. Gottrup, F., Evidence Is a Challenge in Wound Management. The International Journal of Lower Extremity Wounds, 2006. 5(2): pp. 74–75, https://doi.org/10.1177/1534734606288412. (opens in new tab)
  119. 119. Sackett, D.L., et al., Evidence Based Medicine: What It Is and What It Isn’t. BMJ, 1996. 312(7023): pp. 71–72, https://doi.org/10.1136/bmj.312.7023.71. (opens in new tab)
  120. 120. Cochrane. About Us. https://www.cochrane.org/about-us.
  121. 121. Edwards, J. and S. Stapley, Debridement of Diabetic Foot Ulcers. Cochrane Database of Systematic Reviews, 2010. 2010(1): Cd003556, https://doi.org/10.1002/14651858.CD003556.pub2. (opens in new tab)
  122. 122. Gottrup, F., J. Apelqvist, and P. Price, Outcomes in Controlled and Comparative Studies on Non-healing Wounds: Recommendations to Improve the Quality of Evidence in Wound Management. Journal of Wound Care, 2010. 19(6): pp. 237–268, https://doi.org/10.12968/jowc.2010.19.6.48471. (opens in new tab)
  123. 123. Fan, W., et al., Safety and Efficacy of Larval Therapy on Treating Leg Ulcers: A Protocol for Systematic Review and Meta-analysis. BMJ Open, 2020. 10(10): e039898, https://doi.org/10.1136/bmjopen-2020-039898. (opens in new tab)
  124. 124. Whitaker, I.S., et al., Larval Therapy from Antiquity to the Present Day: Mechanisms of Action, Clinical Applications and Future Potential. Postgraduate Medical Journal, 2007. 83(980): pp. 409–413, https://doi.org/10.1136/pgmj.2006.055905. (opens in new tab)
  125. 125. FDA. 510(k) Summary. Monarch Labs, LLC. 2007. https://www.accessdata.fda.gov/cdrh_docs/pdf7/K072438.pdf.
  126. 126. Grassberger, M. and W. Fleischmann, The Biobag — A New Device for the Application of Medicinal Maggots. Dermatology, 2002. 204(4): p. 306, https://doi.org/10.1159/000063369. (opens in new tab)
  127. 127. Sherman, R.A., A New Dressing Design for Use with Maggot Therapy. Plastic and Reconstructive Surgery, 1997. 100(2): pp. 451–456, https://doi.org/10.1097/00006534-199708000-00029. (opens in new tab)
  128. 128. Sherman, R.A. and F.A. Wyle, Low-cost, Low-maintenance Rearing of Maggots in Hospitals, Clinics, and Schools. American Journal of Tropical Medicine and Hygiene, 1996. 54(1): pp. 38–41, https://doi.org/10.4269/ajtmh.1996.54.38. (opens in new tab)
  129. 129. MedMagLabs. Creating Hope in Conflict: A Humanitarian Grand Challenge. http://medmaglabs.com/creating-hope-in-conflict/.
  130. 130. Roy, D. and R. Sherman, Commnetary: Why is Maggot Therapy Not More Commonly Practiced in India? Medical Journal of Dr. D.Y. Patil University, 2014. 7(5): pp. 642–643.
  131. 131. Eamkong, S., S. Pongpanich, and C. Rojanaworarit, Comparison of Curing Costs between Maggot and Conventional Therapies for Chronic Wound Care. Journal of Health Research, 2010. 24(suppl 2): pp. 21–25.
  132. 132. BioMonde. Larval Academy. https://biomonde.com/en/hcp/elearning/larval-academy.
  133. 133. Nigam, Y. Love A Maggot. https://loveamaggot.com/about/.
  134. 134. Mexican Association for Wound Care and Healing. Clinical Practice Guidelines for the Treatment of Acute and Chronic Wounds with Maggot Debridement Therapy. 2010. https://s3.amazonaws.com/aawc-new/memberclicks/GPC_larvatherapy.pdf.
  135. 135. BTER. BioTherapeutics, Education and Research Foundation. https://www.bterfoundation.org/.
  136. 136. Kitching, M., Patients’ Perceptions and Experiences of Larval Therapy. Journal of Wound Care, 2004. 13(1): pp. 25–29, https://doi.org/10.12968/jowc.2004.13.1.26560. (opens in new tab)
  137. 137. Silva, S.M., et al., Terapia larval sob a ótica do paciente. ESTIMA Brazilian Journal of Enterostomal Therapy, 2020. 18(e3020), https://doi.org/10.30886/estima.v18.963_IN.(opens in new tab)